Citadel Advisors
FMTX

Citadel Advisors’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Citadel Advisors’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,100
Closed -$97K – 14140
2022
Q2 		$97K Sell
14,100
-3,900
-22% -$27.4K ﹤0.01% 11441
2022
Q1 		$167K Buy
+18,000
New +$192K ﹤0.01% 11738

Citadel Advisors's FMTX Position: Q4 2022 in Review

Citadel Advisors sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 11,219 shares — an estimated $224K sold.

Citadel Advisors first reported a position in FMTX in Q4 2020 and held it in 6 quarters. The position peaked at $7.56M in Q2 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Citadel Advisors reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 11,219 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $224K.
  • Citadel Advisors first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Citadel Advisors's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $7.56M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.